Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Health Catalyst (HCAT) Revenue (2018 - 2026)

Health Catalyst filings provide 9 years of Revenue readings, the most recent being $70.8 million for Q1 2026.

  • On a quarterly basis, Revenue fell 10.9% to $70.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $302.5 million, a 2.83% decrease, with the full-year FY2025 number at $311.1 million, up 1.48% from a year prior.
  • Revenue hit $70.8 million in Q1 2026 for Health Catalyst, down from $74.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $80.7 million in Q2 2025 to a low of $68.1 million in Q1 2022.
  • Median Revenue over the past 5 years was $74.7 million (2025), compared with a mean of $74.2 million.
  • Biggest five-year swings in Revenue: rose 21.92% in 2022 and later fell 10.9% in 2026.
  • Health Catalyst's Revenue stood at $69.2 million in 2022, then grew by 8.56% to $75.1 million in 2023, then rose by 6.02% to $79.6 million in 2024, then decreased by 6.19% to $74.7 million in 2025, then fell by 5.25% to $70.8 million in 2026.
  • The last three reported values for Revenue were $70.8 million (Q1 2026), $74.7 million (Q4 2025), and $76.3 million (Q3 2025) per Business Quant data.